Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1201
Summit Hotel Properties
INN
$700M
| $6.35M | ﹤0.01% |
975,428
+42,418
| +5% | +$281K |
|
|
KNSW
1202
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $6.34M | ﹤0.01% |
600,000
| – | – |
|
1203
RLJ Lodging Trust
RLJ
$1.69B
| $6.33M | ﹤0.01% |
616,540
+3,520
| +0.6% | +$36.5K |
|
1204
Valmont Industries
VMI
$9.53B
| $6.32M | ﹤0.01% |
21,711
+13,147
| +154% | +$3.8M |
|
1205
EastGroup Properties
EGP
$10.9B
| $6.3M | ﹤0.01% |
36,306
+16,849
| +87% | +$2.81M |
|
1206
BellRing Brands
BRBR
$1.34B
| $6.29M | ﹤0.01% |
171,964
-155,994
| -48% | -$5.59M |
|
1207
AptarGroup
ATR
$8.61B
| $6.28M | ﹤0.01% |
54,180
+43,731
| +419% | +$5.13M |
|
1208
WEX
WEX
$6.31B
| $6.27M | ﹤0.01% |
34,430
+23,655
| +220% | +$4.19M |
|
1209
PUT
Riot Platforms
RIOT
$7.76B
| $6.26M | ﹤0.01% |
529,900
-773,800
| -59% | -$8.66M |
|
1210
First Financial Bankshares
FFIN
$4.97B
| $6.26M | ﹤0.01% |
219,711
+98,704
| +82% | +$2.8M |
|
1211
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $6.25M | ﹤0.01% |
+60,055
| New | +$6.25M |
|
1212
Madrigal Pharmaceuticals
MDGL
$11.8B
| $6.23M | ﹤0.01% |
26,991
-28,344
| -51% | -$7.68M |
|
1213
CALL
Boston Beer
SAM
$1.92B
| $6.23M | ﹤0.01% |
20,200
| – | – |
|
1214
PUT
Akamai
AKAM
$16.1B
| $6.22M | ﹤0.01% |
69,200
-157,200
| -69% | -$13.5M |
|
1215
Texas Pacific Land
TPL
$23.5B
| $6.21M | ﹤0.01% |
42,462
+3,726
| +10% | +$597K |
|
1216
KE Holdings
BEKE
$18.8B
| $6.2M | ﹤0.01% |
417,501
+50,900
| +14% | +$831K |
|
1217
Rio Tinto
RIO
$164B
| $6.2M | ﹤0.01% |
97,059
-305,396
| -76% | -$19.6M |
|
1218
Bright Horizons
BFAM
$3.86B
| $6.19M | ﹤0.01% |
66,916
+26,410
| +65% | +$2.23M |
|
1219
BP
BP
$107B
| $6.17M | ﹤0.01% |
174,907
-71,393
| -29% | -$2.64M |
|
1220
Chemed
CHE
$7.22B
| $6.17M | ﹤0.01% |
11,389
+8,479
| +291% | +$4.64M |
|
1221
Vornado Realty Trust
VNO
$7.38B
| $6.17M | ﹤0.01% |
339,973
-23,135
| -6% | -$341K |
|
1222
FTI Consulting
FCN
$4.18B
| $6.16M | ﹤0.01% |
32,410
+9,939
| +44% | +$1.88M |
|
|
AIRC
1223
DELISTED
Apartment Income REIT Corp.
AIRC
| $6.14M | ﹤0.01% |
170,077
+54,138
| +47% | +$1.93M |
|
1224
PUT
Zoetis
ZTS
$30.5B
| $6.13M | ﹤0.01% |
+35,600
| New | +$6.15M |
|
1225
Viridian Therapeutics
VRDN
$2.67B
| $6.13M | ﹤0.01% |
257,536
+141,393
| +122% | +$3.63M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.